Zoon Kathryn C

SEC Form 4 insider trading activity

Zoon Kathryn C has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: May 4, 2026.

On the most recent filing, Zoon Kathryn C is listed as Director at Emergent BioSolutions Inc. Inside the rolling window, Zoon Kathryn C reported no open-market purchases and 1 open-market sale totaling $144K in EBS.

Companies traded

Other insiders at EBS

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$144K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
EBS
Zoon Kathryn C
Sale$144KMay 4SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Zoon Kathryn C made?

Zoon Kathryn C has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company since 2026.

Which companies does Zoon Kathryn C trade?

Zoon Kathryn C has filed SEC Form 4 disclosures for 1 company, including EBS.

When was Zoon Kathryn C's most recent SEC Form 4 filing?

Zoon Kathryn C's most recent SEC Form 4 filing on Tracefour is dated May 4, 2026.

What is Zoon Kathryn C's total buy and sell value in the current window?

Inside the rolling retention window, Zoon Kathryn C bought $0 and sold $144K based on SEC Form 4 filings.

What was Zoon Kathryn C's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 17,202 EBS shares on 2026-05-01, worth $144K, per SEC Form 4 filings.